RxDoctor Payments Data

Amy Couch

Psychiatric/Mental Health · Winston Salem, NCNPI 1073297727

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.4% of the total across 433 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 17.6% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,735in general payments, 2019–2025

Across 433 payments — averaging $17.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$1K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$815
  • Neurocrine Biosciences, Inc.$756
  • AbbVie$695
  • Otsuka America Pharmaceutical, Inc.$668
  • Axsome Therapeutics, Inc.$573
  • plus $3K from 16 others

What the payments were for

  • Food & beverage$7,69099%
  • Education$451%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,735 in reported general payments places this provider in the 95th percentile of 947 psychiatric/mental health providers in North Carolina.

See all psychiatric/mental health providers in North Carolina

Medicare billing

Part B allowed, 2024
$27,358
Medicare patients
28
Services billed
495

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl19$31,814
Desvenlafaxine Succinate ErDesvenlafaxine Succinate15$1,144
Bupropion XlBupropion Hcl24$465
LoxapineLoxapine Succinate12$368
Risperidone27$364
Olanzapine17$279
Trazodone Hcl35$234
Lithium Carbonate13$211
Duloxetine Hcl16$196
Fluoxetine Hcl23$168
Doxepin Hcl20$167
Lamotrigine17$161
Clonazepam45$140
Hydroxyzine Pamoate12$133
Divalproex Sodium12$106

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$695$31,81419 claims
Teva Pharmaceuticals USA, Inc.Loxapine$253$36812 claims
Almatica Pharma LLCSertraline Hcl$20$812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 947 psychiatric/mental health providers in North Carolina.

Other psychiatric/mental health in Winston Salem

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →